22.12.2022 • NewsNovartisrestructuring

Jobs to Go at Novartis US Headquarters

As part of plans, announced in dribbles, to carve 8,000 jobs out of its global workforce to save $1 billion, Swiss drugs giant Novartis is eliminating 285 staff positions across its headquarters sites in the US state of New Jersey.

Layoffs from the staff of Novartis Services, Novartis Pharmaceuticals and Novartis Corporation in East Hanover will take effect from Jan. 29 according to a local Worker Adjustment and Retraining Notification Act notice.

Affected divisions include the company’s former Pharmaceuticals and Oncology divisions, certain functions of Global Drug Development and business units that were part of Customer Technology.

Additionally, employees in communications, compliance, finance, legal and other units are due to face the axe, as outlined in Novartis’ April 2022 announcement that it planned to merge its pharmaceuticals and oncology businesses into a new unit called Innovative Medicines (IM) and at the same time create separate US and International commercial organizations.

The Swiss drugmaker said it would support staff faced with layoffs with help to include finding new jobs and obtaining career counseling or new positions.

© Novartis
© Novartis

Five ophthalmic drugs to be sold to Harrow

In other US news, Novartis has agreed to sell the rights to five ophthalmic drugs (four of them spray) to US pharma Harrow for $130 million upfront, with $45 million to be paid out if one of them is a market hit.

The five FDA-approved products are Ilevro and Nevanac to relieve eye inflammation in after cataract surgery, Vigamox to treat bacterial conjunctivitis, Maxidex, a steroid eye drop for inflammation and Triesence, an injection for treatment of certain ophthalmic diseases.

Author: Dede Williams, Freelance Journalist

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.